<?xml version='1.0' encoding='utf-8'?>
<document id="21406602"><sentence text="Complex drug interactions of HIV protease inhibitors 1: inactivation, induction, and inhibition of cytochrome P450 3A by ritonavir or nelfinavir."><entity charOffset="121-130" id="DDI-PubMed.21406602.s1.e0" text="ritonavir" /><entity charOffset="134-144" id="DDI-PubMed.21406602.s1.e1" text="nelfinavir" /><pair ddi="false" e1="DDI-PubMed.21406602.s1.e0" e2="DDI-PubMed.21406602.s1.e0" /><pair ddi="false" e1="DDI-PubMed.21406602.s1.e0" e2="DDI-PubMed.21406602.s1.e1" /></sentence><sentence text="Conflicting drug-drug interaction (DDI) studies with the HIV protease inhibitors (PIs) suggest net induction or inhibition of intestinal or hepatic CYP3A" /><sentence text=" As part of a larger DDI study in healthy volunteers, we determined the effect of extended administration of two PIs, ritonavir (RTV) or nelfinavir (NFV), or the induction-positive control rifampin on intestinal and hepatic CYP3A activity as measured by midazolam (MDZ) disposition after a 14-day treatment with the PI in either staggered (MDZ âˆ¼12 h after PI) or simultaneous (MDZ and PI coadministered) manner"><entity charOffset="118-127" id="DDI-PubMed.21406602.s3.e0" text="ritonavir" /><entity charOffset="129-132" id="DDI-PubMed.21406602.s3.e1" text="RTV" /><entity charOffset="137-147" id="DDI-PubMed.21406602.s3.e2" text="nelfinavir" /><entity charOffset="149-152" id="DDI-PubMed.21406602.s3.e3" text="NFV" /><entity charOffset="189-197" id="DDI-PubMed.21406602.s3.e4" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e0" e2="DDI-PubMed.21406602.s3.e0" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e0" e2="DDI-PubMed.21406602.s3.e1" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e0" e2="DDI-PubMed.21406602.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e0" e2="DDI-PubMed.21406602.s3.e3" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e0" e2="DDI-PubMed.21406602.s3.e4" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e1" e2="DDI-PubMed.21406602.s3.e1" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e1" e2="DDI-PubMed.21406602.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e1" e2="DDI-PubMed.21406602.s3.e3" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e1" e2="DDI-PubMed.21406602.s3.e4" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e2" e2="DDI-PubMed.21406602.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e2" e2="DDI-PubMed.21406602.s3.e3" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e2" e2="DDI-PubMed.21406602.s3.e4" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e3" e2="DDI-PubMed.21406602.s3.e3" /><pair ddi="false" e1="DDI-PubMed.21406602.s3.e3" e2="DDI-PubMed.21406602.s3.e4" /></sentence><sentence text=" Oral and intravenous MDZ areas under the plasma concentration-time curves were significantly increased by RTV or NFV and were decreased by rifampin"><entity charOffset="140-148" id="DDI-PubMed.21406602.s4.e0" text="rifampin" /><entity charOffset="107-114" id="DDI-PubMed.21406602.s4.e1" text="RTV" /><entity charOffset="114-121" id="DDI-PubMed.21406602.s4.e2" text="NFV" /><pair ddi="false" e1="DDI-PubMed.21406602.s4.e1" e2="DDI-PubMed.21406602.s4.e1" /><pair ddi="false" e1="DDI-PubMed.21406602.s4.e1" e2="DDI-PubMed.21406602.s4.e2" /><pair ddi="false" e1="DDI-PubMed.21406602.s4.e1" e2="DDI-PubMed.21406602.s4.e0" /><pair ddi="false" e1="DDI-PubMed.21406602.s4.e2" e2="DDI-PubMed.21406602.s4.e2" /><pair ddi="false" e1="DDI-PubMed.21406602.s4.e2" e2="DDI-PubMed.21406602.s4.e0" /></sentence><sentence text=" Irrespective of method of administration, RTV decreased net intestinal and hepatic CYP3A activity, whereas NFV decreased hepatic but not intestinal CYP3A activity"><entity charOffset="43-45" id="DDI-PubMed.21406602.s5.e0" text="RTV" /><entity charOffset="108-110" id="DDI-PubMed.21406602.s5.e1" text="NFV" /><pair ddi="false" e1="DDI-PubMed.21406602.s5.e0" e2="DDI-PubMed.21406602.s5.e0" /><pair ddi="false" e1="DDI-PubMed.21406602.s5.e0" e2="DDI-PubMed.21406602.s5.e1" /></sentence><sentence text=" The magnitude of these DDIs was more accurately predicted using PI CYP3A inactivation parameters generated in sandwich-cultured human hepatocytes rather than human liver microsomes" /><sentence text="" /></document>